1. Home
  2. Analysis
  3. Movicol
  4. Ambrisentan

Movicol and Ambrisentan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Movicol (polyethylene glycol 3350) and Ambrisentan (ambrisentan). Common drug interactions include dyspnoea among females.

The phase IV clinical study analyzes what interactions people have when they take Movicol and Ambrisentan. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Movicol?

Movicol has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 14,249 Movicol users. Check the latest studies of Movicol.

What is Ambrisentan?

Ambrisentan has active ingredients of ambrisentan. eHealthMe is studying from 61,368 Ambrisentan users. Check the latest studies of Ambrisentan.

On Jul, 16, 2026

14 people who take Movicol and Ambrisentan together, and have interactions are studied.

Movicol and Ambrisentan drug interactions.

What are the common drug interactions of Movicol and Ambrisentan, by gender? *:

female:

  1. Dyspnoea (difficult or laboured respiration)
  2. Cardiac failure
  3. Weight increased
  4. Hospitalisation
  5. Oedema (fluid collection in tissue)
  6. Disease progression
  7. Flushing (the warm, red condition of human skin)
  8. Headache (pain in head)
  9. Nausea (feeling of having an urge to vomit)
  10. Pulmonary vascular resistance abnormality

male:

n/a

What are the common drug interactions of Movicol and Ambrisentan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Oedema peripheral (superficial swelling)
  2. Productive cough
  3. Weight decreased
  4. Weight increased
  5. Hospitalisation
  6. Oedema (fluid collection in tissue)
  7. Disease progression
  8. Flushing (the warm, red condition of human skin)
  9. Headache (pain in head)
  10. Nausea (feeling of having an urge to vomit)

60+:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Dyspnoea exertional (breathlessness or shortness of breath)
  3. Renal impairment (severely reduced kidney function)

What are the existing conditions these people have? *

  1. Cellulitis (infection under the skin): 13 people, 92.86%
  2. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 7 people, 50.00%
  3. Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 6 people, 42.86%

* Approximation only. Some reports may have incomplete information.

Do you take Movicol and Ambrisentan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Movicol and Ambrisentan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Movicol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ambrisentan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Movicol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ambrisentan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on polyethylene glycol 3350 and ambrisentan (the active ingredients of Movicol and Ambrisentan, respectively), and Movicol and Ambrisentan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.